BioTricity Inc. Files 8-K on Corporate Matters

Ticker: BTCY · Form: 8-K · Filed: Apr 3, 2024 · CIK: 1630113

Sentiment: neutral

Topics: corporate-governance, filing-update

TL;DR

BIOTRICITY filed an 8-K on April 1st covering corporate changes and votes. Check for details.

AI Summary

BioTricity Inc. filed an 8-K on April 3, 2024, reporting on matters submitted to a vote of security holders and amendments to its articles of incorporation or bylaws, effective April 1, 2024. The filing also includes financial statements and exhibits. The company, formerly MetaSolutions, Inc., is incorporated in Nevada and headquartered in Redwood City, California.

Why It Matters

This filing indicates significant corporate actions, including potential changes to governance or financial structure, which could impact investors' understanding of the company's operational and strategic direction.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure and does not immediately present new financial risks or significant negative events.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of BioTricity Inc.'s security holders?

The filing indicates that matters were submitted to a vote, but the specific details of these matters are not provided in the excerpt.

What were the key amendments to BioTricity Inc.'s articles of incorporation or bylaws?

The filing states that amendments were made to the articles of incorporation or bylaws, but the specific nature of these amendments is not detailed in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on April 1, 2024.

What is BioTricity Inc.'s state of incorporation?

BioTricity Inc. is incorporated in Nevada.

What was BioTricity Inc.'s former company name?

BioTricity Inc.'s former company name was METASOLUTIONS, INC.

Filing Stats: 1,244 words · 5 min read · ~4 pages · Grade level 14.7 · Accepted 2024-04-03 06:07:20

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: April 3, 2024 BIOTRICITY INC. By: /s/ Waqaas Al-Siddiq Waqaas Al-Siddiq Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing